87.5 A

Oxytocin

Also known as: Pitocin, Syntocinon

FDA Approved Research Chemical
Research Evidence 90.0/100
Safety Profile 85.0/100

97 Clinical Trials

Unknown: 9 PHASE4: 9 PHASE3: 6 PHASE2: 14 PHASE1, PHASE2: 2 PHASE1: 6 NA: 46 EARLY_PHASE1: 5

Showing 5 of 97 trials.

20 Research Papers

Showing 5 of 20 papers by citation count.

FDA Data

Not FDA-Approved

Oxytocin has not been evaluated by the FDA for safety or efficacy. It is not approved for human therapeutic use in the United States.

Frequently Asked Questions

Is Oxytocin FDA approved?
No, Oxytocin has not been approved by the FDA for human therapeutic use. It is sold as a research chemical.
How many clinical trials has Oxytocin been studied in?
Oxytocin has been studied in 97 registered clinical trials. CheckPeptides tracks phase, status, and sponsor data for each trial.
What is the trust score for Oxytocin?
Oxytocin has a CheckPeptides trust score of 87.5/100 (grade: A). This score is based on clinical trial volume, research paper quality, FDA data, and evidence classification.
Last verified: April 8, 2026

Quick Facts

Classification
Hypothalamic neuropeptide
Molecular Weight
1007.2 Da
Regulatory Status
N/A

Score Breakdown

Research Evidence 90.0/100
Safety Profile 85.0/100

Evidence Summary

Clinical Trials
97
Research Papers
20
Trust Score
87.5/100
Grade
A

Compare Peptides

See how Oxytocin stacks up against similar peptides.

View Comparisons
← Browse all peptides